Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).

TSXV:SBM - Post by User

Sirona Biochem Corp > Wangbang phase 1

<< Previous

Bullboard Posts

Next >>

Comment by bazooka73on Dec 03, 2021 9:50am

102 Views

Post# 34194261

RE:RE:Wangbang phase 1

Pareto8020 wrote: That's even worse - it took them 3-4 years to even start the Phase I then??

Either way you slice it Wanbang is taking their sweet time and it obviously isn't a priority for them based on the snails pace they've been working on SBM's SGLT2 compound. I would have much rather seen a North Am company run with it - less risk and more exposure.

totally agree. The Wanbang "collaboration" turns out to be an absolute mess!

<< Previous

Bullboard Posts

Next >>

Pembina Pipeline and Haisla Nation finalize Indigenous-owned Cedar LNG